Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultation.

Saved in:
Bibliographic Details
Title: Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultation.
Authors: Corbett A; College of Medicine & Health, Faculty of Life Sciences, University of Exeter, Exeter, UK. a.m.j.corbett@exeter.ac.uk., Sultana J; College of Medicine & Health, Faculty of Life Sciences, University of Exeter, Exeter, UK., Stych K; College of Medicine & Health, Faculty of Life Sciences, University of Exeter, Exeter, UK., Mills R; College of Medicine & Health, Faculty of Life Sciences, University of Exeter, Exeter, UK., Cummings JL; Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, USA., Williams G; Wolfson Sensory, Pain and Regeneration Centre (SPaRC), King's College London, London, SE1 1UL, UK., Ismail Z; College of Medicine & Health, Faculty of Life Sciences, University of Exeter, Exeter, UK.; Departments of Psychiatry, Clinical Neurosciences, Community Health Sciences, and Pathology & Laboratory Medicine, Hotchkiss Brain Institute and O'Brien Institute of Public Health, University of Calgary, Calgary, AB, Canada., Soto-Martin M; Department of Geriatric Medicine, Institute of Ageing, Toulouse University Hospital, University of Toulouse III, Toulouse, F-31073, France., Mintzer J; Ralph H. Johnson VA Medical Center, Medical University of South Carolina, Charleston, USA., Gauthier S; Department of Neurology and Neurosurgery, McGill University, Montreal, Canada., Greig NH; Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, 21224, USA., Noble W; College of Medicine & Health, Faculty of Life Sciences, University of Exeter, Exeter, UK., Killick R; Centre for Healthy Brain Aging, The Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK., Lai MKP; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Kent RidgeRd, Singapore, 117599, Singapore., Routledge C; Alzheimer's Research UK, Cambridge, UK., Walsh F; Wolfson Sensory, Pain and Regeneration Centre (SPaRC), King's College London, London, SE1 1UL, UK., Fillit H; The Icahn School of Medicine at Mount Sinai, New York, NY, 10029-5674, USA.; Alzheimer's Drug Discovery Foundation, New York, NY10019, USA., Aarsland D; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.; Centre for Healthy Brain Ageing, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Lane R; Ionis Pharmaceuticals, Carlsbad, CA, 92010, USA., Mills K; College of Medicine & Health, Faculty of Life Sciences, University of Exeter, Exeter, UK., Ballard C; College of Medicine & Health, Faculty of Life Sciences, University of Exeter, Exeter, UK.
Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2025 Nov 18; Vol. 17 (1), pp. 237. Date of Electronic Publication: 2025 Nov 18.
Publication Type: Journal Article; Review; Consensus Statement
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium: Internet ISSN: 1758-9193 (Electronic) NLM ISO Abbreviation: Alzheimers Res Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1758-9193
DOI:10.1186/s13195-025-01895-4